Cantel Medical (CMN) Misses Q2 EPS by 2c

Cantel Medical (NYSE: CMN) reported Q2 EPS of $0.26, $0.02 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $135.4 million versus the consensus estimate of $142.6 million.

For earnings history and earnings-related data on Cantel Medical (CMN) click here.

You May Also Be Interested In

• PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
• KeyBanc on National Fuel Gas (NFG): 'P&S Growth an Underappreciated Hedge to Weak Natural Gas Prices'
• Criterium Energy signs gas sales deal with PGN, reports Q2 results